BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 31792399)

  • 1. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
    Hinz B; Lagares D
    Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.
    Lagares D; Santos A; Grasberger PE; Liu F; Probst CK; Rahimi RA; Sakai N; Kuehl T; Ryan J; Bhola P; Montero J; Kapoor M; Baron M; Varelas X; Tschumperlin DJ; Letai A; Tager AM
    Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Stiffness: the Conductor of Organ Fibrosis.
    Santos A; Lagares D
    Curr Rheumatol Rep; 2018 Jan; 20(1):2. PubMed ID: 29349703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for Studying Myofibroblast Apoptotic Pathways.
    Zhou Y; Lagares D
    Methods Mol Biol; 2021; 2299():123-137. PubMed ID: 34028739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting.
    Romano E; Rosa I; Fioretto BS; Matucci-Cerinic M; Manetti M
    Curr Mol Med; 2022; 22(3):209-239. PubMed ID: 33823766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.
    Marangoni RG; Korman BD; Wei J; Wood TA; Graham LV; Whitfield ML; Scherer PE; Tourtellotte WG; Varga J
    Arthritis Rheumatol; 2015 Apr; 67(4):1062-73. PubMed ID: 25504959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogramming.
    Merkt W; Zhou Y; Han H; Lagares D
    Wound Repair Regen; 2021 Jul; 29(4):678-691. PubMed ID: 34117675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
    Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts.
    Kuehl T; Lagares D
    Matrix Biol; 2018 Aug; 68-69():94-105. PubMed ID: 29408011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
    Kramann R; DiRocco DP; Humphreys BD
    J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of organ fibrosis.
    Jun JI; Lau LF
    J Clin Invest; 2018 Jan; 128(1):97-107. PubMed ID: 29293097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
    Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
    Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
    Chawla S; Ghosh S
    Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis.
    Dees C; Pötter S; Zhang Y; Bergmann C; Zhou X; Luber M; Wohlfahrt T; Karouzakis E; Ramming A; Gelse K; Yoshimura A; Jaenisch R; Distler O; Schett G; Distler JH
    J Clin Invest; 2020 May; 130(5):2347-2363. PubMed ID: 31990678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.
    Martin K; Pritchett J; Llewellyn J; Mullan AF; Athwal VS; Dobie R; Harvey E; Zeef L; Farrow S; Streuli C; Henderson NC; Friedman SL; Hanley NA; Piper Hanley K
    Nat Commun; 2016 Aug; 7():12502. PubMed ID: 27535340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into myofibroblasts and their activation in scleroderma: opportunities for therapy?
    Gyftaki-Venieri DA; Abraham DJ; Ponticos M
    Curr Opin Rheumatol; 2018 Nov; 30(6):581-587. PubMed ID: 30074511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of endothelial cells to tissue fibrosis.
    Romano E; Rosa I; Fioretto BS; Manetti M
    Curr Opin Rheumatol; 2024 Jan; 36(1):52-60. PubMed ID: 37582200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments on skin fibrosis - Essential signals emanating from the extracellular matrix for the control of myofibroblasts.
    Schulz JN; Plomann M; Sengle G; Gullberg D; Krieg T; Eckes B
    Matrix Biol; 2018 Aug; 68-69():522-532. PubMed ID: 29408278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host responses in tissue repair and fibrosis.
    Duffield JS; Lupher M; Thannickal VJ; Wynn TA
    Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.